Stock Events

Stock Events

Ultragenyx Pharmaceutical (RARE) Q1 2026 Earnings

Feb 12Confirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.81

-1.57

-1.33

-1.09

Details

Expected EPS

-1.092584

Actual EPS

-1.29

Surprise EPS

-0.2

Surprise Percent

-18.07%

Description

⁨Ultragenyx Pharmaceutical⁩ (⁦RARE⁩) has reported earnings of ⁦-1.29⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.